Evaluation of a clinical algorithm involving serum eosinophil cationic protein for guiding the anti-inflammatory treatment of bronchial asthma in childhood

Pediatric Allergy and Immunology

Volumn 11, Issue 2, 2000, Pages 87-94

  Prehn, Antje ^a   Seger, Reinhard A ^a   Torresani, Toni ^a   Molinari, Luciano ^a   Sennhauser, Felix H ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Division of Immunology/Haematology ^*

Author keywords

Asthma therapy; Childhood asthma; S ECP; SCG; Topical steroids

Indexed keywords

ANTIINFLAMMATORY AGENT; BUDESONIDE; CROMOGLYCATE DISODIUM; EOSINOPHIL CATIONIC PROTEIN; STEROID; TERBUTALINE;

ALGORITHM; ARTICLE; ASTHMA; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EOSINOPHIL; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; METERED DOSE INHALER; PATIENT COMPLIANCE; PEDIATRICS; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0034122011     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2000.00079.x     Document Type: Article

References (29)

1. BOUSQUET J, CHANEZ P, LACOSTE JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990: 323: 1033-9.
2. MARTIN AJ, LANDAU LI, PHELAN PD. Predicting the course of asthma in children. Aust Paediatr J 1982: 18: 84-7.
3. AGERTOFT L, PEDERSEN S. Effects of long-term treatment with inhaled corticosteroids on growth and pulmonary function in asthmatic children. Respir Med 1994: 88: 373-81.
4. WARNER JO, NASPITZ CK, CROPP GJA. Third International Pediatric Consensus Statement on the Management of Childhood Asthma. Pediatr Pulmonol 1998: 25: 1-17.
5. Schweizerische Gesellschaft für Pädiatric/schweizerische Gesellschaft für Pneumologie/ Arbeitsgruppe pädiatrische Pneumologie. Asthma bronchiale bei Säuglingen, Kindern und Jugendlichen: Therapieempfehlungen 1996. Paediatrica 1996: 7: 3-6.
6. VAN ESSEN-ZANDVLIET EE, HUGHES MD, WAALKENS HJ, et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 1992: 146: 547-54.
7. BONER AL, DE STEFANO G, PIACENTINI GL, et al. Perception of broncho-constriction in chronic asthma. J Asthma 1992: 29: 323-30.
8. KÖNIG P. Hidden asthma in childhood. Am J Dis Child 1981: 135: 1053-5.
9. ROBERTSON CF, RUBINFELD AR, BOWES G. Pediatric asthma deaths in Victoria: the mild are at risk. Pediatr Pulmonol 1992: 13: 95-100.
10. DJUKANOVIC R, LAI CKW, WILSON JW, et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992: 5: 538-44.
11. SYNEK M, BEASLEY R, FREW AJ, et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 1996: 154: 224-30.
12. PIZZICHINI E, PIZZICHINI MM, EFTHIMIADIS A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996: 154: 308-17.
13. WARDLAW AJ, DUNNETTE S, GLEICH GJ, COLLINS JV, KAY AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988: 137: 62-9.
14. HAAHTHELA T, JÄRVINEN M, KAVA T, et al. Comparison of a β2-agonist, Terbutaline, with an inhaled corticosteroid, Budesonide, in newly detected asthma. N Engl J Med 1991: 325: 388-92.
15. KÖNIG P, SHAFFER J. The effect of drug therapy on long-term outcome of childhood asthma: a possible preview of international guidelines. J Allergy Clin Immunol 1996: 98: 1103-11.
16. TASCHE MJA, VAN DER WOUDEN CJ, UIJEN JHJM, et al. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. Lancet 1997: 350: 1060-4.
17. ODDERA S, SILVESTRI M, BALBO A, et al. Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsivenes in patients with mild to moderate, stable asthma. Allergy 1996: 51: 100-7.
18. KOLLER DY, HEROUY Y, GÖTZ M, et al. Clinical value of monitoring eosinophil activity in asthma. Arch Dis Child 1995: 73: 413-7.
19. PREHN A, SEGER RA, FABER J, TORRESANI T, MOLINARI L, GERBER A, SENNHAUSER FH. The relation of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma. Pediatr Allergy Immunol 1998: 9: 197-203.
20. ZIMMERMANN B, LANNER A, ENENDER I, et al. Total eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993: 23: 564-70.
21. WEVER MJ, WEVER-HESS HERMANS J. The use of serum eosinophil cationic protein (S-ECP) in the management of steroid therapy in chronic asthma. Clin Exp Allergy 1996: 27: 519-29.
22. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987: 136: 225-44.
23. BRAUN-FAHRLÄNDER C, GASSNER M, GRIZE L, et al. Prevalence of hay fever and allergic sensitization in farmers' children and their peers living in the same rural community. Clin Exp Allergy 1999: 29: 28-34.
24. SENNHAUSER FH, KÜHNI CE. Prevalence of respiratory symptoms in Swiss children: is bronchial asthma really more prevalent in boys? Pediatr Pulmonol 1995: 19: 161-6.
25. PRONK-ADMIRAAL CJ, BARTELS PCM. Effect of clotting temperature and eosinophil concentration on the eosinophil cationic protein concentration in serum. Scand J Clin Lab Invest 1994: 54: 185-8.
26. AHLSTEDT S, PETERSON CGB, ENANDER I. Update in allergy testing in childhood asthma: how do you know whether you arc successfully controlling the patient's inflammation? Pediatr Pulmonol 1995: 11 (Suppl.): 32-3.
27. VAN ESSEN-ZANDVLIET EE, HUGHES MD, WAALKENS HJ, DUIVERMAN EJ, KERREBIJN KF and the Dutch CNSLD study group. Remission of childhood asthma after long-term treatment with inhaled corticosteroid (Budesonide): can it be achieved? Eur Respir J 1994: 7: 63-8.
28. CARLSEN KH, HALVORSEN R, PETTERSEN M, CARLSEN KC. Inflammation markers and symptom activity in children with bronchial asthma. Influence of atopy and eczema. Pediatr Allergy Immunol 1997: 8: 112-20.
29. MILGROM H, BENDER B, ACKERSON L, BOWRY P, SMITH B, RAND C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996: 98: 1051-7.